NHRI Enters Technology Transfer Agreement of DBPR186 with Taivex Therapeutics Corp.

National Health Research Institutes (NHRI) and Tai…

Continue reading

Share Button

Congratulation to DBPR807 team on receiving the 18th National Innovation Award in the Academic Research Category

“Development of CXCR4-Targeting Antagonists for Ac…

Continue reading

Share Button

Congratulation to DBPR807 team on receiving the 18th National Innovation Award in the Academic Research Category

“Development of CXCR4-Targeting Antagonists for Ac…

Continue reading

Share Button

Congratulation to DBPR211 team on receiving the 18th National Innovation Award in the Renewal and Issue the Excelsior Award

“Discovery and development of novel anti-diabetic …

Continue reading

Share Button

NHRI Enters Technology Transfer Agreement of DBPR114 with LaunXP Biomedical Co., Ltd.

National Health Research Institutes (NHRI) and Lau…

Continue reading

Share Button

NHRI Enters Technology Transfer Agreement of DBPR215 with Jiayi Biomedical Co., Ltd.

National Health Research Institutes (NHRI) and Jia…

Continue reading

Share Button

National Health Research Institutes Announces the Initiation of Phase I Clinical Trial of DBPR115, A Novel Small-molecule Drug Conjugate (SMDC), in Taiwan

With budget supporting from Ministry of Economic A…

Continue reading

Share Button

NHRI Enters Technology Transfer Agreement of DBPR211 with Applied Biopharma LLC, wholly owned by Agentix Corp. (AGTX) in the US

National Health Research Institutes (NHRI) and App…

Continue reading

Share Button

Congratulations! Dr. Ta-Yuan Chang is elected as a member of the U.S. National Academy of Sciences.

We are honored to announce a good news that Profes…

Continue reading

Share Button

A Safer Opioid Painkiller with Low Side-Effects─NHRI has discovered a series of opioid receptor/nociception receptor dual agonists with fast and potent antinociception, fewer side-effects than morphine

The Ministry of Science and Technology has present…

Continue reading

Share Button